NASDAQ

Enliven Therapeutics, Inc. (ELVN)

♥ 730 Thanks from members

Live price chart, market sentiment, and community perspectives for Enliven Therapeutics, Inc. (NASDAQ: ELVN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: OrbiMed AdvisorsFounder: Enliven ScientificLeadership: Keelen Morrison (CEO)Leadership: Benjamin Dachis (CFO)Holder: OrbiMed AdvisorsHolder: RA Capital ManagementHolder: Fidelity ManagementELVN-001 (BCR-ABL inhibitor)ELVN-002 (HER2 kinase inhibitor)#ELVN#Enliven Therapeutics#biotech stock#precision oncology#NASDAQ